← FDA Drug Approvals (Drugs@FDA)
LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG
NDA · New Drug Application · Sponsor: HETERO DRUGS LTD · Approved 2009-05-07
Drug application
- FDA Application #
NDA022356- Application type
- New Drug Application
- Brand name
- LAMIVUDINE, ZIDOVUDINE TABS 150MG/300MG CO-PACKAGED WITH NEVIRAPINE TABS 200MG
- Generic name
- Lamivudine
- Active ingredients
- LAMIVUDINE; ZIDOVUDINE; NEVIRAPINE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- HETERO DRUGS LTD
- First approval
- 2009-05-07
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown